Stock traders buy large volume of call options from Forte Biosciences (NASDAQ: FBRX)


Forte Biosciences, Inc. (NASDAQ:FBRX – Get Rating) saw some unusual options trading on Wednesday. Investors bought 30,205 call options on the stock. This represents an increase of approximately 1,663% from the typical daily volume of 1,713 call options.

The NASDAQ FBRX opened at $1.40 on Thursday. The company has a 50-day simple moving average of $1.40 and a 200-day simple moving average of $2.03. Forte Biosciences has a 1-year low of $1.18 and a 1-year high of $7.26.

Several institutional investors have recently bought and sold shares of FBRX. BlackRock Inc. increased its position in Forte Biosciences shares by 5.9% during the fourth quarter. BlackRock Inc. now owns 817,063 shares of the company worth $1,748,000 after purchasing an additional 45,337 shares during the period. Goldman Sachs Group Inc. increased its stake in Forte Biosciences by 554.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 85,240 shares of the company worth $182,000 after purchasing an additional 72,206 shares during the period. Deutsche Bank AG increased its stake in Forte Biosciences by 683.0% in the fourth quarter. Deutsche Bank AG now owns 64,050 shares of the company valued at $137,000 after buying an additional 55,870 shares last quarter. Parametric Portfolio Associates LLC increased its equity stake in Forte Biosciences by 57.2% during the fourth quarter. Parametric Portfolio Associates LLC now owns 174,724 shares of the company valued at $374,000 after purchasing an additional 63,582 shares during the period. Finally, Squarepoint Ops LLC bought a new position in shares of Forte Biosciences during Q4 for a value of approximately $28,000. Hedge funds and other institutional investors own 36.29% of the company’s shares.

Forte Biosciences Company Profile (Get a rating)

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It develops the FB-102 program which treats various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Read more



Get news and reviews for Forte Biosciences Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Forte Biosciences and related companies with MarketBeat.com’s FREE daily newsletter.

Comments are closed.